Therapeutic Cloning
President Bush probably will not reverse his position on stem cell research, even if it is mostly symbolic (embryos, after all, are destroyed every day in reproductive clinics–perhaps some White House press corps member would ask the president about this someday). The battle over therapeutic cloning, however, goes on in the Senate. And it appears that a ban on such cloning, lacking the support of Senators such as Orrin Hatch and Arlen Specter, probably would not muster a simple majority in the Senate–much less the 60 votes needed to break a filibuster. “The question is whether the Democrats and stem-cell supporters among Republicans can still hang tough,” says one observer, especially when contentious Supreme Court appointments loom in the near future. Some hope that passage of Proposition 71 in California will put pressure on President Bush to change his stem cell policy, a proposition that unfortunately looks unlikely from this president.
Keep Reading
Most Popular

The dark secret behind those cute AI-generated animal images
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.

Inside Charm Industrial’s big bet on corn stalks for carbon removal
The startup used plant matter and bio-oil to sequester thousands of tons of carbon. The question now is how reliable, scalable, and economical this approach will prove.

The hype around DeepMind’s new AI model misses what’s actually cool about it
Some worry that the chatter about these tools is doing the whole field a disservice.

How Charm Industrial hopes to use crops to cut steel emissions
The startup believes its bio-oil, once converted into syngas, could help clean up the dirtiest industrial sector.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.